全文获取类型
收费全文 | 25293篇 |
免费 | 1450篇 |
国内免费 | 20篇 |
出版年
2021年 | 247篇 |
2019年 | 234篇 |
2018年 | 397篇 |
2017年 | 355篇 |
2016年 | 589篇 |
2015年 | 751篇 |
2014年 | 897篇 |
2013年 | 1208篇 |
2012年 | 1319篇 |
2011年 | 1359篇 |
2010年 | 851篇 |
2009年 | 733篇 |
2008年 | 1055篇 |
2007年 | 1099篇 |
2006年 | 987篇 |
2005年 | 1029篇 |
2004年 | 941篇 |
2003年 | 938篇 |
2002年 | 886篇 |
2001年 | 413篇 |
2000年 | 348篇 |
1999年 | 318篇 |
1998年 | 255篇 |
1992年 | 337篇 |
1991年 | 320篇 |
1990年 | 262篇 |
1989年 | 285篇 |
1988年 | 315篇 |
1987年 | 335篇 |
1986年 | 306篇 |
1985年 | 338篇 |
1984年 | 320篇 |
1983年 | 262篇 |
1982年 | 205篇 |
1981年 | 200篇 |
1980年 | 223篇 |
1979年 | 351篇 |
1978年 | 259篇 |
1977年 | 241篇 |
1976年 | 222篇 |
1975年 | 252篇 |
1974年 | 363篇 |
1973年 | 340篇 |
1972年 | 297篇 |
1971年 | 294篇 |
1970年 | 296篇 |
1969年 | 308篇 |
1968年 | 230篇 |
1967年 | 225篇 |
1966年 | 199篇 |
排序方式: 共有10000条查询结果,搜索用时 965 毫秒
1.
Based on its proven anabolic effects on bone in osteoporosis patients, recombinant parathyroid hormone (PTH1-34) has been evaluated as a potential therapy for skeletal repair. In animals, the effect of PTH1-34 has been investigated in various skeletal repair models such as fractures, allografting, spinal arthrodesis and distraction
osteogenesis. These studies have demonstrated that intermittent PTH1-34 treatment enhances and accelerates the skeletal repair process via a number of mechanisms, which include effects on mesenchymal
stem cells, angiogenesis, chondrogenesis, bone formation and resorption. Furthermore, PTH1-34 has been shown to enhance bone repair in challenged animal models of aging, inflammatory arthritis and glucocorticoid-induced
bone loss. This pre-clinical success has led to off-label clinical use and a number of case reports documenting PTH1-34 treatment of delayed-unions and non-unions have been published. Although a recently completed phase 2 clinical trial of PTH1-34 treatment of patients with radius fracture has failed to achieve its primary outcome, largely because of effective healing
in the placebo group, several secondary outcomes are statistically significant, highlighting important issues concerning the
appropriate patient population for PTH1-34 therapy in skeletal repair. Here, we review our current knowledge of the effects of PTH1-34 therapy for bone healing, enumerate several critical unresolved issues (e.g., appropriate dosing regimen and indications)
and discuss the long-term potential of this drug as an adjuvant for endogenous tissue engineering. 相似文献
2.
3.
4.
5.
A new simple enzymatic method for measuring AMP content in freeze-clamped rat heart is presented. The method is based on the ammonia estimation after the deamination of 5'-AMP by muscle 5'-adenylic acid deaminase. The minimum detectable amount of AMP was about 1.5 nmol. The recovery of AMP added to the tissue homogenate was 94%. The variance coefficient evaluated by assaying five samples from one tissue extract was equal to 5%. AMP content of rat heart (0.28 mumol/g wet tissue) is comparable with the values reported by others. 相似文献
6.
7.
8.
A Ba?sset J Cotonat P Montastruc 《Comptes rendus des séances de la Société de biologie et de ses filiales》1975,169(2):444-448
The authors have studied in the dog--normal or diabetic insipidus after hypothalamic lesion--submitted to oral ingestion of ethanol the effects of a few antidiuretic drug: chlorpropamid, atromid-S, carbamazepin and carisoprodol. The carisoprodol only can reduce the diuresis and the drinking provoked by ethanol. 相似文献
9.
10.
Edward Harrison 《BMJ (Clinical research ed.)》1916,1(2888):645-647